The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis.
Nat Commun
; 15(1): 3962, 2024 May 10.
Article
in En
| MEDLINE
| ID: mdl-38730247
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Chalcones
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Nat Commun
Journal subject:
BIOLOGIA
/
CIENCIA
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: